progesterone
Commercial- Indications
- Infertility, Menopause, Hormonal disorders
Company intelligence / Profile preview
Zhejiang Aisheng Pharmaceutical is a Chinese pharmaceutical company focused on the development and production of generic drugs, particularly in the area of women’s health. The company has completed clinical bioequivalence studies for products such as drospirenone/ethinyl estradiol tablets and dydrogesterone tablets, and has secured regulatory approval for a generic version of progesterone vaginal sustained-release gel. Its pipeline includes several oral contraceptives and hormone therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Aisheng Pharmaceutical.